Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

NCT02848170 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: CS-3150
DRUG: olmesartan medoxomil

Sponsor

Daiichi Sankyo Co., Ltd.